Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
MiNK Therapeutics, Inc. (INKT) had Return on Tangible Equity of 12.70% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.77M |
|
-- |
|
-- |
|
$2.70M |
|
$-2.70M |
|
$-0.07M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.77M |
|
$-2.70M |
|
$-2.65M |
|
3.96M |
|
3.96M |
|
$-0.70 |
|
$-0.70 |
|
| Balance Sheet Financials | |
$3.58M |
|
$0.69M |
|
$0.69M |
|
$4.27M |
|
$12.12M |
|
-- |
|
$13.94M |
|
$26.06M |
|
$-21.79M |
|
$-21.79M |
|
$-21.79M |
|
3.97M |
|
| Cash Flow Statement Financials | |
$-1.34M |
|
-- |
|
$0.00M |
|
$4.58M |
|
$3.23M |
|
$-1.34M |
|
$0.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-- |
|
-0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
12.70% |
|
|
Return on Tangible Equity |
12.70% |
-64.83% |
|
12.70% |
|
$-5.49 |
|
$-0.34 |
|
$-0.34 |
|